InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: iandy post# 76918

Friday, 09/30/2016 6:50:19 PM

Friday, September 30, 2016 6:50:19 PM

Post# of 458315
Biogen news was "A Shot Across the Bow." CEO Missling has steadfastly insisted that the Alzheimer's trial will be partnered. These negotiations are under way. Biogen is clearly a player here and some might say have the upper hand having inked a minor deal already. If one believes in the potential of this Company then one would be at great peril to be light shares of the Company at the present time IF one wants to be invested with AVXL. I am and I added an additional 10% today.
GLTAL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News